CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: The reprogramming efficiency of peripheral CML CD34+ cells was lower than that of CB-CD34+ control cells (0.01% vs 0.1%, respectively), and delayed (21 days vs 14 days).